NorthStar Medical Radioisotopes is routinely manufacturing copper-67(Cu-67) on its electron accelerators for Clarity Pharmaceuticals.
Clarity is using the isotope for its therapy clinical programs, NorthStar said. The deal is part of an exclusive agreement for NorthStar to supply Cu-67 to Clarity for three active theranostic clinical trials that are assessing the safety and efficacy of radiopharmaceuticals Cu-67 SAR-bisPSMA, Cu-67 SAR-Bombesin and Cu-67 SARTATE, NorthStar said.
